Page last updated: 2024-09-03

luzindole and sincalide

luzindole has been researched along with sincalide in 1 studies

Compound Research Comparison

Studies
(luzindole)
Trials
(luzindole)
Recent Studies (post-2010)
(luzindole)
Studies
(sincalide)
Trials
(sincalide)
Recent Studies (post-2010) (sincalide)
26511194,01572533

Protein Interaction Comparison

ProteinTaxonomyluzindole (IC50)sincalide (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0006
Cholecystokinin receptor type AHomo sapiens (human)0.0006
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0008
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cevik-Aras, H; Ekström, J1

Other Studies

1 other study(ies) available for luzindole and sincalide

ArticleYear
Anti-inflammatory action of cholecystokinin and melatonin in the rat parotid gland.
    Oral diseases, 2010, Volume: 16, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Escherichia coli; Hormone Antagonists; Injections, Intraperitoneal; Lipopolysaccharides; Lysine; Melatonin; Neutrophil Infiltration; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Organ Size; Parasympathectomy; Parotid Gland; Parotitis; Peroxidase; Proglumide; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Melatonin, MT2; Sincalide; Sympathectomy; Tryptamines

2010